| 46.18 BATS BZX Real-Time Price As of 12:54pm ET |  +0.76 / +1.67%Today’s Change | 29.22 Today|||52-Week Range 111.36 | +40.49% Year-to-Date |
| Previous close | 45.42 |
| Today’s open | 45.55 |
| Day’s range | 45.17 - 46.61 |
| Volume | 37,074 |
| Average volume (3 months) | 2,444,560 |
| Market cap | $6.5B |
| Earnings growth (last year) | +43.63% |
| Earnings growth (this year) | +726.77% |
| Earnings growth (next 5 years) | -7.38% |
| Revenue growth (last year) | +86.00% |
| P/E ratio | 11.2 |
| Price/Sales | 30.27 |
| Price/Book | 67.84 |
| Today’s change | Today’s % change | |
|---|---|---|
| BLUEbluebird bio Inc | +2.59 | +2.05% |
| TECHBio-Techne Corp | +2.15 | +1.33% |
| EXASExact Sciences Corp | +2.22 | +2.94% |
| NBIXNeurocrine Bioscienc... | +1.74 | +1.96% |
| Next reporting date | February 28, 2019 |
| EPS forecast (this quarter) | -$0.68 |
| Annual revenue (last year) | $307.7M |
| Annual profit (last year) | -$96.7M |
| Net profit margin | -31.42% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Howard W. Robin |
Chief Operating Officer & Senior Vice President John Nicholson |
Corporate headquarters San Francisco, California |
